What is Lazarus 3D?
Lazarus 3D operates at the intersection of advanced manufacturing and clinical precision. The company specializes in the production of highly customized, patient-specific anatomical models that serve critical functions across multiple industries. By providing high-fidelity replicas, the firm assists medical device manufacturers in navigating complex FDA trial requirements, while simultaneously offering surgeons a platform to test novel techniques and devices in a risk-free environment.
Beyond the clinical sphere, the company has carved out a unique niche in the legal sector, providing detailed exhibits that translate complex anatomical data into accessible visual evidence. This dual-market approach—combining deep-tech medical innovation with high-value legal support—positions Lazarus 3D as a versatile player in the additive manufacturing landscape. Their business model is built upon the bedrock of custom work, ensuring that each output is tailored to the specific, often life-critical, needs of their diverse clientele.
How much funding has Lazarus 3D raised?
Lazarus 3D has raised a total of $6M across 1 funding round:
Angel/Seed
$6M
Angel/Seed (2022): $6M with participation from Ecliptic Capital
Key Investors in Lazarus 3D
Ecliptic Capital
Ecliptic Capital is an early-stage innovation fund that utilizes a modern, open-ended investment platform to support deep-tech and hard science inventions across various industries.
What's next for Lazarus 3D?
With the recent capital deployment, Lazarus 3D is poised to expand its operational capacity and refine its proprietary modeling processes. The strategic focus will likely shift toward scaling production to meet the increasing demand for surgical simulation tools, which are becoming essential for modern medical training and device validation. Furthermore, the company is expected to leverage this investment to enhance its technological infrastructure, potentially integrating more sophisticated materials and faster turnaround times for its enterprise partners.
As the firm moves forward, the emphasis will remain on maintaining the high standards of accuracy required for FDA-regulated environments. By continuing to bridge the gap between hard science and practical application, Lazarus 3D is set to capture a larger share of the medical technology market, driving long-term value for its stakeholders and setting new benchmarks for custom anatomical modeling.
